CHARLES G. MOERTEL, M.D.; J. ARNOLD BARGEN, M.D., F.A.C.P.
Of the many disease states that the internist or general practitioner may be called upon to treat, few if any have proved to be more frustrating to the physician and more demoralizing to the patient than chronic ulcerative colitis. Evaluation of any form of therapy in this disease is a most complex task, since it occurs in varied clinical forms and in varied degrees of severity. In many cases the natural history is one of exacerbations and remissions. Therefore, any therapeutic agent, if given at an opportune time or for a sufficiently long period, may be coincident with an unrelated
MOERTEL CG, BARGEN JA. A CRITICAL ANALYSIS OF THE USE OF SALICYLAZOSULFAPYRIDINE IN CHRONIC ULCERATIVE COLITIS(A CRITICAL ANALYSIS OF THE USE OF SALICYLAZOSULFAPYRIDINE IN CHRONIC ULCERATIVE COLITIS*). Ann Intern Med. 1959;51:879–889. doi: 10.7326/0003-4819-51-5-879
Download citation file:
Published: Ann Intern Med. 1959;51(5):879-889.
Gastroenterology/Hepatology, Inflammatory Bowel Disease.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use